Your browser doesn't support javascript.
loading
Effectiveness and safety of rivaroxaban compared with low-molecular-weight heparin in cancer-associated thromboembolism.
Costa, Olivia S; Kohn, Christine G; Kuderer, Nicole M; Lyman, Gary H; Bunz, Thomas J; Coleman, Craig I.
Afiliação
  • Costa OS; Department of Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, CT.
  • Kohn CG; Evidence-Based Practice Center, Hartford Hospital, Hartford, CT.
  • Kuderer NM; Evidence-Based Practice Center, Hartford Hospital, Hartford, CT.
  • Lyman GH; Department of Pharmacy Practice, University of Connecticut School of Medicine, Farmington, CT.
  • Bunz TJ; Division of Hematology and Seattle Cancer Care Alliance, University of Washington, Seattle, WA.
  • Coleman CI; Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle WA.
Blood Adv ; 4(17): 4045-4051, 2020 09 08.
Article em En | MEDLINE | ID: mdl-32853381
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tromboembolia Venosa / Neoplasias Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tromboembolia Venosa / Neoplasias Idioma: En Ano de publicação: 2020 Tipo de documento: Article